Pharsight

Drugs that contain Betamethasone Dipropionate; Calcipotriene

1. Enstilar patents expiration

ENSTILAR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6753013 LEO PHARMA AS Pharmaceutical composition
Jan, 2020

(4 years ago)

US10130640 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US9119781 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10688108 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US9566286 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10617698 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10682364 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10716799 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10660908 LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Jun, 2031

(7 years from now)

US10130640

(Pediatric)

LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Dec, 2031

(7 years from now)

US9119781

(Pediatric)

LEO PHARMA AS Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
Dec, 2031

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Pediatric Exclusivity(PED) Jan 30, 2023
New Patient Population(NPP) Jul 30, 2022
New Product(NP) Oct 16, 2018

Market Authorisation Date: 16 October, 2015

Treatment: Plaque psoriasis; Topical treatment of plaque psoriasis in patients 12 years and older

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of ENSTILAR before it's drug patent expiration?
More Information on Dosage

ENSTILAR family patents

Family Patents

2. Taclonex patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE39706 LEO PHARMA AS Crystalline form of a vitamin D analogue
Jun, 2015

(8 years ago)

US5763426 LEO PHARMA AS Crystalline form of a vitamin D analogue
Jun, 2015

(8 years ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6787529 LEO PHARMA AS Topical composition
Jan, 2020

(4 years ago)

US6753013 LEO PHARMA AS Pharmaceutical composition
Jan, 2020

(4 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Dec 23, 2017

Market Authorisation Date: 09 January, 2006

Treatment: Treatment of moderate plaque psoriasis; Psoriasis

Dosage: OINTMENT;TOPICAL

How can I launch a generic of TACLONEX before it's drug patent expiration?
More Information on Dosage

TACLONEX family patents

Family Patents

3. Wynzora patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10265265 MC2 Topical composition
Sep, 2027

(3 years from now)

US11638711 MC2 NULL
Mar, 2039

(14 years from now)

US11696919 MC2 Topical composition
Mar, 2039

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Dosage Form(NDF) Jul 20, 2023

Market Authorisation Date: 20 July, 2020

Treatment: NA

Dosage: CREAM;TOPICAL

More Information on Dosage

WYNZORA family patents

Family Patents